Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Parsons

Showing results (351-360 of 373) with videos related to

Pageof 38
Sort By:
JCO Clinical Cancer Informatics|April 12, 2024
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin LymphomaRasmus Rask Kragh Jørgensen, Fanny Bergström, Sandra Eloranta, et al.
Journal of the National Cancer Institute|October 21, 2022
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trialsMichael E Roth, Susan K Parsons, Patricia A Ganz, et al.
Prostate Cancer and Prostatic Diseases|January 13, 2016
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRIK C McCammack, C J Kane, J K Parsons, et al.
Prostate Cancer and Prostatic Diseases|January 7, 2015
Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extensionR A Rakow-Penner, N S White, J K Parsons, et al.
Bone Marrow Transplantation|May 7, 2021
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantationDeborah Friedman, Allen J Dozor, Jordan Milner, et al.
NEJM Evidence|June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's LymphomaAngie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
JCO Oncology Practice|January 22, 2024
Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALLJulie A Wolfson, Allison C Grimes, Michelle Nuno, et al.
British Journal of Haematology|October 17, 2024
External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registryValeria Buccheri, Frederico Rafael Moreira, Irene Biasoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Pageof 38

Showing results (351-360 of 373) with videos related to

Sort By:
Pageof 38
JCO Clinical Cancer Informatics|April 12, 2024
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin LymphomaRasmus Rask Kragh Jørgensen, Fanny Bergström, Sandra Eloranta, et al.
Journal of the National Cancer Institute|October 21, 2022
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trialsMichael E Roth, Susan K Parsons, Patricia A Ganz, et al.
Prostate Cancer and Prostatic Diseases|January 13, 2016
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRIK C McCammack, C J Kane, J K Parsons, et al.
Prostate Cancer and Prostatic Diseases|January 7, 2015
Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extensionR A Rakow-Penner, N S White, J K Parsons, et al.
Bone Marrow Transplantation|May 7, 2021
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantationDeborah Friedman, Allen J Dozor, Jordan Milner, et al.
NEJM Evidence|June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's LymphomaAngie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
JCO Oncology Practice|January 22, 2024
Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALLJulie A Wolfson, Allison C Grimes, Michelle Nuno, et al.
British Journal of Haematology|October 17, 2024
External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registryValeria Buccheri, Frederico Rafael Moreira, Irene Biasoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Pageof 38